結果ページ11 セクター：医療 産業：バイオテクノロジー 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
すべての国
- {{country.name}}
- すべての国
- 米国 (646)
- オーストラリア (44)
- オーストリア (11)
- ベルギー (7)
- ブラジル (13)
- カナダ (47)
- 中国 (89)
- デンマーク (6)
- フィンランド (3)
- フランス (26)
- ドイツ (443)
- 香港 (45)
- インド (21)
- イスラエル (13)
- イタリア (3)
- 日本 (37)
- メキシコ (26)
- オランダ (3)
- ニュージーランド (1)
- ノルウェー (10)
- ポーランド (8)
- ロシア (1)
- 韓国 (79)
- スペイン (3)
- スウェーデン (58)
- スイス (10)
- 台湾 (60)
- タイ (2)
- トルコ (1)
- イギリス (25)
全取引所
- {{item.name}}
- 全取引所
- Amsterdam (3)
- Aquis AQSE (1)
- ASX (44)
- Brussels (7)
- BSE (13)
- Canadian Sec (21)
- Cboe CA (3)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (389)
- Hamburg (1)
- Helsinki (3)
- HKSE (45)
- IOB (24)
- Istanbul (1)
- KOSDAQ (69)
- KSE (10)
- MCE (3)
- MCX (1)
- Mexico (26)
- Milan (3)
- Munich (16)
- NSE (8)
- NYSE (6)
- NYSE American (14)
- NZSE (1)
- Oslo (10)
- OTC Markets EXMKT (39)
- OTC Markets OTCPK (107)
- OTC Markets OTCQB (29)
- OTC Markets OTCQX (5)
- Paris (26)
- São Paulo (13)
- Shanghai (46)
- Shenzhen (43)
- Stockholm (58)
- Stuttgart (21)
- Swiss (10)
- Taipei Exchange (53)
- Taiwan (7)
- Tech Market Large (153)
- Tech Market Middle (83)
- Tech Market Small (210)
- Tel Aviv (13)
- Thailand (2)
- Tokyo (37)
- Toronto (8)
- TSXV (15)
- Vienna (11)
- Warsaw (8)
- XETRA (15)
バイオテクノロジー (1741)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | 予測 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | 予測 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
ABL Bio Inc.
298380.KQ
KR
|
₩93,100 70.28 USD |
+3.22
|
₩5T 3.87B USD | ₩789K 595.31 USD | ₩85,600 64.61 USD | ₩93,100 70.28 USD | ₩5T 3.87B USD | 0 | ₩0 0 USD | ||
Catalyst Pharmaceuticals, Inc.
CN2.F
DE
|
€26.90 31.05 USD |
+0.75
|
€3.29B 3.8B USD | €500.00 577.17 USD | €26.90 31.05 USD | €26.90 31.05 USD | €3.29B 3.8B USD | 17.93 | €1.50 1.73 USD | ||
|
LigaChem Biosciences Inc.
141080.KQ
KR
|
₩134,800 101.75 USD |
+2.98
|
₩5T 3.7B USD | ₩529K 399.18 USD | ₩121,200 91.49 USD | ₩139,900 105.6 USD | ₩5T 3.7B USD | 0 | ₩0 0 USD | ||
ACADIA Pharmaceuticals Inc.
DR6.F
DE
|
€18.36 21.19 USD |
-1.77
|
€3.14B 3.63B USD | €630.00 727.23 USD | €18.36 21.19 USD | €18.36 21.19 USD | €3.14B 3.63B USD | 9.55 | €1.92 2.22 USD | ||
|
Crinetics Pharmaceuticals, Inc.
6Z4.F
DE
|
€29.31 33.83 USD |
-0.75
|
€3.09B 3.57B USD | €364.00 420.18 USD | €29.31 33.83 USD | €29.31 33.83 USD | €3.09B 3.57B USD | 0 | -€4.46 -5.1 USD | ||
Genscript Biotech
GNNSF
US
|
$1.60 — |
0
|
$3.50B — | $300.00 — | $1.90 — | $1.90 — | $3.50B — | 0 | -$0.25 — | ||
Denali Therapeutics Inc.
4DN.F
DE
|
€17.82 20.57 USD |
+0.51
|
€2.83B 3.26B USD | €1.23K 1.42K USD | €17.82 20.57 USD | €17.82 20.57 USD | €2.83B 3.26B USD | 0 | -€2.50 -2.8 USD | ||
Denali Therapeutics Inc.
4DN.MU
DE
|
€17.72 20.45 USD |
0
|
€2.81B 3.25B USD | €0.00 0 USD | €17.72 20.45 USD | €17.72 20.45 USD | €2.81B 3.25B USD | 0 | -€2.50 -2.8 USD | ||
|
Lakefront Biotherapeutics
GLPGF
US
|
$48.70 — |
+43.24
|
$3.21B — | $190.00 — | $26.20 — | $26.20 — | $3.21B — | 5.70 | $8.54 — | ||
|
Genscript Biotech Corporation
G51.F
DE
|
€1.27 1.47 USD |
+1.6
|
€2.77B 3.2B USD | €40.00 46.17 USD | €1.27 1.47 USD | €1.27 1.47 USD | €2.77B 3.2B USD | 0 | -€0.21 -0.2 USD | ||
Telix Pharmaceuticals
TLPPF
US
|
$9.41 — |
0
|
$3.19B — | $1.20K — | $9.50 — | $9.50 — | $3.19B — | 0 | -$0.02 — | ||
Viking Therapeutics, Inc.
1VT.F
DE
|
€23.65 27.3 USD |
-4.44
|
€2.75B 3.17B USD | €270.00 311.67 USD | €23.65 27.3 USD | €23.65 27.3 USD | €2.75B 3.17B USD | 0 | -€3.60 -4.1 USD | ||
Nektar Therapeutics
NKTR.MX
MX
|
MX$1,584.15 93.8 USD |
0
|
MX$53.52B 3.17B USD | MX$0.00 0 USD | MX$1,584.15 93.8 USD | MX$1,584.15 93.8 USD | MX$53.52B 3.17B USD | 0 | -MX$138.60 -8.2 USD | ||
|
Zealand Pharma A/S
22Z.F
DE
|
€38.20 44.1 USD |
+3.1
|
€2.67B 3.08B USD | €35.00 40.4 USD | €37.40 43.17 USD | €38.20 44.1 USD | €2.67B 3.08B USD | 3.17 | €12.05 13.91 USD | ||
Zealand Pharma A/S
ZLDPF
US
|
$43.66 — |
+3.88
|
$3.06B — | $100.00 — | $43.66 — | $43.66 — | $3.06B — | 3.02 | $14.43 — | ||
|
Camurus AB (publ)
7CA.F
DE
|
€42.86 49.47 USD |
-13.76
|
€2.55B 2.94B USD | €10.00 11.54 USD | €42.86 49.47 USD | €42.86 49.47 USD | €2.55B 2.94B USD | 40.81 | €1.05 1.21 USD | ||
BB Biotech AG
BBZA.DE
DE
|
€45.35 52.35 USD |
0
|
€2.50B 2.89B USD | €15.08K 17.41K USD | €44.70 51.6 USD | €46.00 53.1 USD | €2.50B 2.89B USD | 0 | -€8.60 -9.9 USD | ||
|
BB Biotech AG
BBZA.F
DE
|
€45.05 52 USD |
+0.67
|
€2.48B 2.87B USD | €1.00 1.15 USD | €45.05 52 USD | €45.05 52 USD | €2.48B 2.87B USD | 0 | -€8.60 -9.9 USD | ||
|
Voronoi, Inc.
310210.KQ
KR
|
₩207,000 156.25 USD |
+4.55
|
₩4T 2.81B USD | ₩183K 137.99 USD | ₩187,800 141.76 USD | ₩207,000 156.25 USD | ₩4T 2.81B USD | 0 | ₩0 0 USD | ||
BioArctic AB (publ)
0RV2.IL
GB
|
SEK 281.00 27.43 USD |
-0.14
|
SEK 28.11B 2.74B USD | SEK 62.00 6.05 USD | SEK 281.00 27.43 USD | SEK 281.00 27.43 USD | SEK 28.11B 2.74B USD | 91.53 | SEK 3.07 0.3 USD | ||
|
IDEAYA Biosciences, Inc.
30J.SG
DE
|
€23.81 27.48 USD |
+0.13
|
€2.25B 2.6B USD | €0.00 0 USD | €23.76 27.43 USD | €23.81 27.48 USD | €2.25B 2.6B USD | 0 | -€1.36 -1.5 USD | ||
|
IDEAYA Biosciences, Inc.
30J.F
DE
|
€23.75 27.42 USD |
-1.62
|
€2.25B 2.59B USD | €300.00 346.3 USD | €23.75 27.42 USD | €23.75 27.42 USD | €2.25B 2.59B USD | 0 | -€1.36 -1.5 USD | ||
BioArctic AB (publ)
B9A.F
DE
|
€25.12 29 USD |
-2.48
|
€2.23B 2.57B USD | €33.00 38.09 USD | €25.12 29 USD | €25.12 29 USD | €2.23B 2.57B USD | 114.18 | €0.22 0.25 USD | ||
|
Bavarian Nordic A/S
0DPB.IL
GB
|
DKK 181.85 26.66 USD |
+0.08
|
DKK 17.07B 2.5B USD | DKK 6.00 0.88 USD | DKK 181.85 26.66 USD | DKK 181.85 26.66 USD | DKK 17.07B 2.5B USD | 12.90 | DKK 14.09 2.07 USD | ||
|
Zealand Pharma A/S
0NZU.IL
GB
|
DKK 285.80 41.9 USD |
-0.23
|
DKK 17.04B 2.5B USD | DKK 1.26K 185.18 USD | DKK 281.60 41.29 USD | DKK 286.10 41.95 USD | DKK 17.04B 2.5B USD | 0 | -DKK 15.13 -2.2 USD | ||
SK bioscience Co.,Ltd.
302440.KS
KR
|
₩39,350 29.7 USD |
+1.94
|
₩3T 2.33B USD | ₩181K 136.82 USD | ₩37,150 28.04 USD | ₩39,500 29.82 USD | ₩3T 2.33B USD | 0 | ₩0 0 USD | ||
|
Celldex Therapeutics, Inc.
TCE2.F
DE
|
€25.05 28.92 USD |
-0.79
|
€1.97B 2.27B USD | €200.00 230.87 USD | €25.05 28.92 USD | €25.05 28.92 USD | €1.97B 2.27B USD | 0 | -€3.71 -4.2 USD | ||
|
PharmaResearch Co., Ltd.
214450.KQ
KR
|
₩288,500 217.77 USD |
+2.49
|
₩3T 2.26B USD | ₩203K 153.36 USD | ₩271,500 204.94 USD | ₩293,500 221.54 USD | ₩3T 2.26B USD | 0 | ₩0 0 USD | ||
Ultragenyx Pharmaceutical Inc.
UP0.F
DE
|
€19.76 22.81 USD |
+2.09
|
€1.95B 2.25B USD | €229.00 264.34 USD | €19.76 22.81 USD | €19.76 22.81 USD | €1.95B 2.25B USD | 0 | -€5.29 -6.1 USD | ||
|
89bio
ETNB
US
|
$14.84 — |
0
|
$2.20B — | $0.00 — | $0.00 — | $0.00 — | $2.20B — | 0 | $0.00 — | ||
Pharvaris N.V.
9EN.F
DE
|
€26.90 31.05 USD |
-0.92
|
€1.88B 2.17B USD | €300.00 346.3 USD | €26.90 31.05 USD | €26.90 31.05 USD | €1.88B 2.17B USD | 0 | -€2.72 -3.1 USD | ||
Bavarian Nordic A/S
BVNRY
US
|
$9.30 — |
+0.54
|
$2.13B — | $300.00 — | $9.30 — | $9.30 — | $2.13B — | 11.92 | $0.78 — | ||
|
BAVARIAN NORDIC N
BV3.DE
DE
|
€24.16 27.89 USD |
0
|
€1.85B 2.13B USD | €606.00 699.53 USD | €24.16 27.89 USD | €24.16 27.89 USD | €1.85B 2.13B USD | 11.84 | €2.04 2.35 USD | ||
Bavarian Nordic A/S
BVNKF
US
|
$27.82 — |
0
|
$2.13B — | $4.00 — | $29.41 — | $29.41 — | $2.13B — | 11.83 | $2.35 — | ||
Bavarian Nordic A/S
BV3.F
DE
|
€23.82 27.5 USD |
-0.75
|
€1.82B 2.1B USD | €400.00 461.73 USD | €23.82 27.5 USD | €23.82 27.5 USD | €1.82B 2.1B USD | 11.67 | €2.04 2.35 USD | ||
|
Genus
GENSF
US
|
$31.07 — |
0
|
$2.06B — | $145.00 — | $35.00 — | $35.00 — | $2.06B — | 32.70 | $0.95 — | ||
|
Mesoblast
MEOBF
US
|
$1.55 — |
0
|
$2.00B — | $5.00K — | $1.70 — | $1.70 — | $2.00B — | 0 | -$0.07 — | ||
|
Hugel, Inc.
145020.KQ
KR
|
₩245,500 185.31 USD |
+2.51
|
₩3T 2B USD | ₩61K 46.15 USD | ₩232,000 175.12 USD | ₩245,500 185.31 USD | ₩3T 2B USD | 0 | ₩0 0 USD | ||
|
Aurinia Pharmaceuticals Inc.
IKAP.F
DE
|
€13.25 15.29 USD |
-1.23
|
€1.70B 1.97B USD | €530.00 611.8 USD | €13.25 15.29 USD | €13.25 15.29 USD | €1.70B 1.97B USD | 7.08 | €1.87 2.16 USD | ||
Kodiak Sciences Inc.
K27.F
DE
|
€26.89 31.04 USD |
+1.17
|
€1.68B 1.94B USD | €30.00 34.63 USD | €26.89 31.04 USD | €26.89 31.04 USD | €1.68B 1.94B USD | 0 | -€3.62 -4.1 USD | ||
|
Vericel Corporation
ATQP.F
DE
|
€32.20 37.17 USD |
+1.26
|
€1.64B 1.9B USD | €100.00 115.43 USD | €32.20 37.17 USD | €32.20 37.17 USD | €1.64B 1.9B USD | 87.02 | €0.37 0.43 USD | ||
|
OliX Pharmaceuticals, Inc
226950.KQ
KR
|
₩124,300 93.83 USD |
+0.89
|
₩2T 1.89B USD | ₩395K 298.49 USD | ₩112,000 84.54 USD | ₩124,300 93.83 USD | ₩2T 1.89B USD | 0 | ₩0 0 USD | ||
|
Lakefront Biotherapeutics NV
GXE.DE
DE
|
€24.64 28.44 USD |
0
|
€1.62B 1.87B USD | €9.00 10.39 USD | €24.44 28.21 USD | €24.64 28.44 USD | €1.62B 1.87B USD | 3.32 | €7.41 8.55 USD | ||
|
Lakefront Biotherapeutics NV
GXEA.F
DE
|
€24.60 28.4 USD |
+1.65
|
€1.62B 1.87B USD | €86.00 99.27 USD | €24.60 28.4 USD | €24.60 28.4 USD | €1.62B 1.87B USD | 3.31 | €7.41 8.55 USD | ||
|
Lakefront Biotherapeutics NV
0JXZ.IL
GB
|
€24.54 28.33 USD |
+0.04
|
€1.62B 1.87B USD | €10.00 11.54 USD | €24.54 28.33 USD | €24.54 28.33 USD | €1.62B 1.87B USD | 0 | -€2.44 -2.8 USD | ||
|
Lakefront Biotherapeutics NV
GXE.F
DE
|
€24.44 28.21 USD |
0
|
€1.61B 1.86B USD | €500.00 577.17 USD | €24.44 28.21 USD | €24.44 28.21 USD | €1.61B 1.86B USD | 3.29 | €7.41 8.55 USD | ||
Ocular Therapeutix, Inc.
0OT.F
DE
|
€7.35 8.48 USD |
+1.38
|
€1.61B 1.86B USD | €2.00K 2.31K USD | €7.35 8.48 USD | €7.35 8.48 USD | €1.61B 1.86B USD | 0 | -€1.25 -1.4 USD | ||
Maravai LifeSciences Holdings, Inc.
MAR.F
DE
|
€4.36 5.03 USD |
0
|
€1.61B 1.86B USD | €2.00K 2.31K USD | €4.36 5.03 USD | €4.36 5.03 USD | €1.61B 1.86B USD | 0 | -€0.62 -0.7 USD | ||
|
Zai Lab Limited
1ZL.F
DE
|
€14.20 16.39 USD |
+3.65
|
€1.60B 1.84B USD | €420.00 484.82 USD | €14.20 16.39 USD | €14.20 16.39 USD | €1.60B 1.84B USD | 0 | -€1.48 -1.7 USD | ||
|
Genus plc
GBE.F
DE
|
€24.00 27.7 USD |
0
|
€1.59B 1.84B USD | €3.00 3.46 USD | €24.00 27.7 USD | €24.00 27.7 USD | €1.59B 1.84B USD | 29.26 | €0.82 0.95 USD | ||
Lakefront Biotherapeutics NV
G1LP34.SA
BR
|
R$6.88 1.39 USD |
0
|
R$9.07B 1.84B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$9.07B 1.84B USD | 3.15 | R$2.18 0.44 USD | ||
|
Biotest AG
BIO.HM
DE
|
€40.00 46.17 USD |
+2.04
|
€1.58B 1.83B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €1.58B 1.83B USD | 0 | -€0.63 -0.7 USD | ||
|
Mesoblast Limited
LWB.F
DE
|
€1.20 1.38 USD |
-1.03
|
€1.55B 1.79B USD | €1.50K 1.73K USD | €1.20 1.38 USD | €1.20 1.38 USD | €1.55B 1.79B USD | 0 | -€0.06 -0.06 USD | ||
Lakefront Biotherapeutics NV
GLPG.VI
AT
|
€23.22 26.8 USD |
0
|
€1.53B 1.77B USD | €0.00 0 USD | €23.10 26.67 USD | €23.34 26.94 USD | €1.53B 1.77B USD | 3.13 | €7.41 8.55 USD | ||
|
Stoke Therapeutics, Inc.
0GT.F
DE
|
€24.38 28.14 USD |
-4.65
|
€1.52B 1.75B USD | €606.00 699.53 USD | €24.38 28.14 USD | €24.38 28.14 USD | €1.52B 1.75B USD | 0 | -€2.48 -2.8 USD | ||
|
Viridian Therapeutics, Inc.
1S1.F
DE
|
€13.70 15.81 USD |
-2.14
|
€1.51B 1.75B USD | €2.09K 2.41K USD | €13.70 15.81 USD | €13.70 15.81 USD | €1.51B 1.75B USD | 0 | -€2.91 -3.3 USD | ||
|
Galecto
GLTO
US
|
$28.69 — |
0
|
$1.73B — | $0.00 — | $0.00 — | $0.00 — | $1.73B — | 0 | $0.00 — | ||
Agios Pharmaceuticals, Inc.
8AP.F
DE
|
€24.80 28.63 USD |
+3.33
|
€1.47B 1.7B USD | €180.00 207.78 USD | €24.80 28.63 USD | €24.80 28.63 USD | €1.47B 1.7B USD | 0 | -€6.30 -7.2 USD | ||
|
Vir Biotechnology, Inc.
VIR.MX
MX
|
MX$170.00 10.07 USD |
0
|
MX$28.67B 1.7B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$28.67B 1.7B USD | 0 | -MX$54.03 -3.1 USD | ||
|
Iovance Biotherapeutics, Inc.
2LB.F
DE
|
€3.29 3.79 USD |
-1.2
|
€1.47B 1.69B USD | €1.00K 1.15K USD | €3.29 3.79 USD | €3.29 3.79 USD | €1.47B 1.69B USD | 0 | -€0.80 -0.9 USD | ||
|
uniQure N.V.
UQ1.F
DE
|
€23.20 26.78 USD |
+2.65
|
€1.46B 1.69B USD | €250.00 288.58 USD | €23.20 26.78 USD | €23.20 26.78 USD | €1.46B 1.69B USD | 0 | -€3.03 -3.4 USD | ||
Innoviva, Inc.
HVE.F
DE
|
€19.80 22.86 USD |
+2.59
|
€1.46B 1.69B USD | €207.00 238.95 USD | €19.80 22.86 USD | €19.80 22.86 USD | €1.46B 1.69B USD | 3.64 | €5.43 6.27 USD | ||
|
RAPT Therapeutics
RAPT
US
|
$58.02 — |
0
|
$1.68B — | $0.00 — | $0.00 — | $0.00 — | $1.68B — | 0 | $0.00 — | ||
Pharma Mar
PHMMF
US
|
$93.00 — |
+2.7
|
$1.68B — | $152.00 — | $93.00 — | $93.00 — | $1.68B — | 17.51 | $5.31 — | ||
Pharma Mar, S.A.
PMRA.F
DE
|
€83.10 95.93 USD |
-0.89
|
€1.45B 1.67B USD | €112.00 129.29 USD | €83.10 95.93 USD | €83.10 95.93 USD | €1.45B 1.67B USD | 17.98 | €4.62 5.33 USD | ||
|
Sarepta Therapeutics, Inc.
S1RP34.SA
BR
|
R$3.90 0.79 USD |
-3.47
|
R$8.23B 1.67B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$8.23B 1.67B USD | 43.33 | R$0.09 0.02 USD | ||
|
Intellia Therapeutics, Inc.
38I.F
DE
|
€10.28 11.87 USD |
-9.82
|
€1.44B 1.66B USD | €500.00 577.17 USD | €10.28 11.87 USD | €10.28 11.87 USD | €1.44B 1.66B USD | 0 | -€3.06 -3.5 USD | ||
|
Nanobiotix S.A.
5NRA.F
DE
|
€28.20 32.55 USD |
-0.7
|
€1.43B 1.65B USD | €59.00 68.11 USD | €28.20 32.55 USD | €28.20 32.55 USD | €1.43B 1.65B USD | 0 | -€0.50 -0.5 USD | ||
Sarepta Therapeutics, Inc.
AB3A.F
DE
|
€13.06 15.08 USD |
-4.53
|
€1.38B 1.59B USD | €75.00 86.58 USD | €13.06 15.08 USD | €13.06 15.08 USD | €1.38B 1.59B USD | 43.53 | €0.30 0.35 USD | ||
Ascentage Pharma Group International
36X.F
DE
|
€3.68 4.25 USD |
-1.6
|
€1.37B 1.59B USD | €21.00 24.24 USD | €3.68 4.25 USD | €3.68 4.25 USD | €1.37B 1.59B USD | 0 | -€0.45 -0.5 USD | ||
|
Nanobiotix S.A.
5NR.F
DE
|
€26.62 30.73 USD |
-4.11
|
€1.35B 1.56B USD | €345.00 398.25 USD | €26.62 30.73 USD | €26.62 30.73 USD | €1.35B 1.56B USD | 0 | -€0.50 -0.5 USD | ||
|
Oxford Nanopore Technologies plc
4R0.F
DE
|
€1.38 1.6 USD |
-3.08
|
€1.35B 1.55B USD | €435.00 502.14 USD | €1.38 1.6 USD | €1.38 1.6 USD | €1.35B 1.55B USD | 0 | -€0.17 -0.1 USD | ||
|
Syndax Pharmaceuticals, Inc.
1T3.F
DE
|
€15.19 17.53 USD |
+0.4
|
€1.35B 1.55B USD | €913.00 1.05K USD | €15.19 17.53 USD | €15.19 17.53 USD | €1.35B 1.55B USD | 0 | -€2.42 -2.7 USD | ||
|
AbCellera Biologics Inc.
8QQ.F
DE
|
€4.25 4.9 USD |
-3.85
|
€1.30B 1.5B USD | €100.00 115.43 USD | €4.25 4.9 USD | €4.25 4.9 USD | €1.30B 1.5B USD | 0 | -€0.42 -0.4 USD | ||
|
AtaiBeckley Inc.
9VC.F
DE
|
€3.55 4.09 USD |
0
|
€1.29B 1.49B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €1.29B 1.49B USD | 0 | €0.00 0 USD | ||
|
AtaiBeckley Inc.
9VC.DE
DE
|
€3.43 3.95 USD |
0
|
€1.27B 1.47B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €1.27B 1.47B USD | 0 | €0.00 0 USD | ||
|
Idorsia
IDRSF
US
|
$5.75 — |
0
|
$1.47B — | $250.00 — | $4.40 — | $4.40 — | $1.47B — | 0 | -$1.29 — | ||
|
Mind Medicine (MindMed)
MNMD
US
|
$15.02 — |
0
|
$1.46B — | $0.00 — | $0.00 — | $0.00 — | $1.46B — | 0 | $0.00 — | ||
|
Palvella Therapeutics Inc. R
PI6.F
DE
|
€88.00 101.58 USD |
-2.22
|
€1.26B 1.46B USD | €6.00 6.93 USD | €88.00 101.58 USD | €88.00 101.58 USD | €1.26B 1.46B USD | 0 | -€3.62 -4.1 USD | ||
Capricor Therapeutics, Inc.
4LN2.F
DE
|
€21.76 25.12 USD |
-0.78
|
€1.26B 1.45B USD | €2.00K 2.31K USD | €21.76 25.12 USD | €21.76 25.12 USD | €1.26B 1.45B USD | 0 | -€2.01 -2.3 USD | ||
Novavax, Inc.
NVAX.MX
MX
|
MX$148.00 8.76 USD |
0
|
MX$24.34B 1.44B USD | MX$9.00 0.53 USD | MX$148.00 8.76 USD | MX$148.00 8.76 USD | MX$24.34B 1.44B USD | 0 | -MX$9.78 -0.5 USD | ||
|
Ascletis Pharma
ASCLF
US
|
$1.35 — |
0
|
$1.42B — | $1.00K — | $1.35 — | $1.35 — | $1.42B — | 0 | -$0.05 — | ||
|
SELLAS Life Sciences Group, Inc.
RXK3.F
DE
|
€6.16 7.11 USD |
-5.81
|
€1.21B 1.4B USD | €4.14K 4.78K USD | €6.16 7.11 USD | €6.16 7.11 USD | €1.21B 1.4B USD | 0 | -€0.20 -0.2 USD | ||
|
Immunocore Holdings plc
6YG.F
DE
|
€23.80 27.47 USD |
0
|
€1.21B 1.4B USD | €4.00 4.62 USD | €23.80 27.47 USD | €23.80 27.47 USD | €1.21B 1.4B USD | 0 | -€0.49 -0.5 USD | ||
KalVista Pharmaceuticals, Inc.
4XC1.F
DE
|
€22.73 26.24 USD |
0
|
€1.21B 1.4B USD | €300.00 346.3 USD | €22.73 26.24 USD | €22.73 26.24 USD | €1.21B 1.4B USD | 0 | -€3.42 -3.9 USD | ||
|
Precigen, Inc.
I5X.F
DE
|
€3.38 3.9 USD |
+6.96
|
€1.21B 1.39B USD | €500.00 577.17 USD | €3.38 3.9 USD | €3.38 3.9 USD | €1.21B 1.39B USD | 0 | -€1.05 -1.2 USD | ||
|
GH Research PLC
1KA.F
DE
|
€17.30 19.97 USD |
-1.7
|
€1.19B 1.37B USD | €400.00 461.73 USD | €17.30 19.97 USD | €17.30 19.97 USD | €1.19B 1.37B USD | 0 | -€0.79 -0.9 USD | ||
|
Ardelyx, Inc.
41X.F
DE
|
€4.80 5.54 USD |
+0.31
|
€1.19B 1.37B USD | €2.55K 2.94K USD | €4.80 5.54 USD | €4.80 5.54 USD | €1.19B 1.37B USD | 0 | -€0.21 -0.2 USD | ||
|
Ascletis Pharma Inc.
2VJ.F
DE
|
€1.10 1.27 USD |
0
|
€1.16B 1.34B USD | €700.00 808.03 USD | €1.10 1.27 USD | €1.10 1.27 USD | €1.16B 1.34B USD | 0 | -€0.05 -0.05 USD | ||
|
UroGen Pharma Ltd.
UR8.F
DE
|
€23.75 27.42 USD |
-0.17
|
€1.16B 1.34B USD | €65.00 75.03 USD | €23.75 27.42 USD | €23.75 27.42 USD | €1.16B 1.34B USD | 0 | -€2.38 -2.7 USD | ||
SanBio Company
SNBIF
US
|
$16.45 — |
0
|
$1.28B — | $1.00K — | $3.85 — | $3.85 — | $1.28B — | 0 | -$0.33 — | ||
CureVac N.V.
0A9E.IL
GB
|
$5.13 — |
0
|
$1.28B — | $0.00 — | $0.00 — | $0.00 — | $1.28B — | 0 | $0.00 — | ||
Immatics N.V.
4A3.F
DE
|
€7.59 8.76 USD |
-3.19
|
€1.04B 1.2B USD | €96.00 110.82 USD | €7.59 8.76 USD | €7.59 8.76 USD | €1.04B 1.2B USD | 0 | -€1.71 -1.9 USD | ||
|
Everest Medicines Limited
6HN.F
DE
|
€2.88 3.32 USD |
-1.37
|
€1.01B 1.17B USD | €101.00 116.59 USD | €2.88 3.32 USD | €2.88 3.32 USD | €1.01B 1.17B USD | 0 | -€0.11 -0.1 USD | ||
|
Neuren Pharmaceuticals
NURPF
US
|
$8.88 — |
0
|
$1.12B — | $250.00 — | $9.25 — | $9.25 — | $1.12B — | 55.46 | $0.16 — | ||
|
Inventiva
IVEVF
US
|
$5.33 — |
0
|
$1.11B — | $100.00 — | $4.00 — | $4.00 — | $1.11B — | 0 | -$2.19 — | ||
|
CStone Pharmaceuticals
CSPHF
US
|
$0.69 — |
0
|
$1.11B — | $4.00K — | $0.68 — | $0.70 — | $1.11B — | 0 | -$0.05 — | ||
MannKind Corporation
NNFN.F
DE
|
€3.08 3.56 USD |
+0.39
|
€951.88M 1.1B USD | €10.00 11.54 USD | €3.08 3.56 USD | €3.08 3.56 USD | €951.88M 1.1B USD | 0 | -€0.06 -0.06 USD | ||
MedinCell S.A.
MEB.F
DE
|
€25.64 29.6 USD |
-1.99
|
€920.65M 1.06B USD | €285.00 328.99 USD | €25.64 29.6 USD | €25.64 29.6 USD | €920.65M 1.06B USD | 0 | -€0.61 -0.7 USD | ||
|
CureVac
CVAC
US
|
$4.66 — |
0
|
$1.05B — | $0.00 — | $0.00 — | $0.00 — | $1.05B — | 0 | $0.00 — | ||
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
|||||||||||